JAGX (Jaguar Animal Health) Earnings per share for the last four quarters

Public company logo of Jaguar Health Corp (JAGX)

Jaguar Health, Inc. (JAGX) relies on inelastic demand for Mytesi within a narrow segment. However, geopolitical strife is blocking the supply of tropical raw materials and restricting exports, as confirmed by the trailing twelve months (ttm) earnings per share growth rate. Limited sales scale coupled with high margins creates an efficiency plateau. The value of 92.10 characterizes this parameter for assessing current profitability.

JAGX (Jaguar Health, Inc.) Net earnings per share (EPS TTM) history from 02/11/2024 to 11/18/2026

Financial and market metric breakdowns for Jaguar Health Corp (JAGX)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental company valuation:JAGX - Jaguar Health Inc
Signature product of Jaguar Animal Health

For Jaguar Health, Inc. (JAGX), the market valuation depends directly on earnings per share dynamics. By analyzing the YoY EPS growth rate (trailing 12 months), an investor can observe the annual change in net income while accounting for daily exchange rate fluctuations. This metric reveals the actual profitability trend between quarterly reports. A stable staff of botanical scientists minimizes operational risks, supporting the fundamental base. However, a strengthening dollar could offset the positive momentum of this indicator.